Largest pharmaceuticals by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Veradermics has the lowest figure of the 61 pharmaceuticals ranked by total liabilities, at PLN 36.8M, followed by Belite Bio (PLN 40.4M) and Oruka Therapeutics (PLN 67M). Figures as of 18 Nov 2026, 14:43 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- VeradermicsPLN 36.8M
- Median
- PLN 8.4B
- Combined market value
- PLN 20.67T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | VeradermicsMANE · Health Care | PLN 36.8M | PLN 21.6B | PLN 511.46 | 1.18% up | 233% up | ||
| 2 | Belite BioBLTE · Health Care | PLN 40.4M | PLN 25.7B | PLN 633.89 | 0.10% up | 31% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | PLN 67M | PLN 26.8B | PLN 395.60 | 2.29% up | 241% up | ||
| 4 | Edgewise TherapeuticsEWTX · Health Care | PLN 121.8M | PLN 18.5B | PLN 168.88 | 0.05% up | 88% up | ||
| 5 | Dianthus TherapeuticsDNTH · Health Care | PLN 150.7M | PLN 19.7B | PLN 349.47 | 0.06% up | 113% up | ||
| 6 | Protagonist TherapeuticsPTGX · Health Care | PLN 214.7M | PLN 32.8B | PLN 502.39 | 0.36% up | 46% up | ||
| 7 | Praxis Precision MedicinesPRAX · Health Care | PLN 240M | PLN 34.4B | PLN 1,230.64 | 0.47% up | 61% up | ||
| 8 | Spyre TherapeuticsSYRE · Health Care | PLN 251.1M | PLN 36.6B | PLN 384.88 | 2.18% up | 286% up | ||
| 9 | ErascaERAS · Health Care | PLN 285M | PLN 19.5B | PLN 55.65 | 0.22% down | 403% up | ||
| 10 | Summit TherapeuticsSMMT · Health Care | PLN 370.7M | PLN 33.7B | PLN 42.08 | 1.78% down | 36% down | ||
| 11 | Definium TherapeuticsDFTX · Health Care | PLN 432.7M | PLN 16.2B | PLN 118.33 | 0.31% up | 169% up | ||
| 12 | ABIVAXABVX · Health Care | PLN 575.3M | PLN 29.3B | PLN 334.77 | 1.55% up | 27% down | ||
| 13 | Corcept TherapeuticsCORT · Health Care | PLN 758.3M | PLN 30.7B | PLN 280.67 | 0.24% down | 8% down | ||
| 14 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | PLN 787.1M | PLN 30.3B | PLN 385.34 | 0.90% up | 126% up | ||
| 15 | Rhythm PharmaceuticalsRYTM · Health Care | PLN 843.9M | PLN 32.1B | PLN 463.56 | 0.99% down | 13% up | ||
| 16 | Cogent BiosciencesCOGT · Health Care | PLN 1.2B | PLN 19.9B | PLN 114.43 | 2.33% up | 20% down | ||
| 17 | TG TherapeuticsTGTX · Health Care | PLN 1.7B | PLN 38.5B | PLN 254.39 | 1.03% up | 107% up | ||
| 18 | Roivant SciencesROIV · Health Care | PLN 1.7B | PLN 113B | PLN 156.01 | 0.37% up | 90% up | ||
| 19 | Travere TherapeuticsTVTX · Health Care | PLN 2B | PLN 19.7B | PLN 205.20 | 0.01% up | 44% up | ||
| 20 | Mirum PharmaceuticalsMIRM · Health Care | PLN 2.1B | PLN 24.2B | PLN 370.17 | 0.26% up | 31% up | ||
| 21 | Ligand PharmaceuticalsLGND · Health Care | PLN 2.2B | PLN 23.7B | PLN 1,184.54 | 0.41% up | 43% up | ||
| 22 | Axsome TherapeuticsAXSM · Health Care | PLN 2.4B | PLN 28.7B | PLN 545.43 | 0.08% down | 7% down | ||
| 23 | Madrigal PharmaceuticalsMDGL · Health Care | PLN 2.6B | PLN 39.2B | PLN 1,686.65 | 0.46% down | 24% down | ||
| 24 | AlkermesALKS · Health Care | PLN 2.7B | PLN 31.3B | PLN 185.99 | 1.91% up | 58% up | ||
| 25 | Legend BiotechLEGN · Health Care | PLN 2.9B | PLN 13.2B | PLN 68.14 | 5.34% up | 42% down | ||
| 26 | United TherapeuticsUTHR · Health Care | PLN 3.1B | PLN 100B | PLN 2,347.44 | 0.09% up | 23% up | ||
| 27 | Arrowhead PharmaceuticalsARWR · Health Care | PLN 3.5B | PLN 24.5B | PLN 173.36 | 0.43% up | 10% up | ||
| 28 | BioMarin PharmaceuticalBMRN · Health Care | PLN 6.1B | PLN 45.9B | PLN 237.02 | 0.89% up | 11% up | ||
| 29 | InsmedINSM · Health Care | PLN 6.1B | PLN 107B | PLN 487.89 | 0.29% down | 40% down | ||
| 30 | Ascendis PharmaASND · Health Care | PLN 6.5B | PLN 71.1B | PLN 1,084.08 | 0.44% down | 28% up | ||
| 31 | CytokineticsCYTK · Health Care | PLN 8.4B | PLN 29.1B | PLN 208.71 | 0.64% up | 20% down | ||
| 32 | Dr. Reddy's LaboratoriesRDY · Health Care | PLN 8.5B | PLN 50B | PLN 60.03 | 1.01% up | 5% up | ||
| 33 | BridgeBio PharmaBBIO · Health Care | PLN 12.1B | PLN 60.3B | PLN 309.66 | 0.42% up | 17% up | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | PLN 12.2B | PLN 18.3B | PLN 109.62 | 1.26% up | 64% down | ||
| 35 | PTC TherapeuticsPTCT · Health Care | PLN 12.5B | PLN 20.3B | PLN 243.20 | 0.35% up | 20% down | ||
| 36 | Amneal PharmaceuticalsAMRX · Health Care | PLN 14.7B | PLN 30B | PLN 85.97 | 1.37% up | 83% up | ||
| 37 | BeOne MedicinesONC · Health Care | PLN 15.4B | PLN 187.2B | PLN 1,638.83 | 1.24% down | 17% up | ||
| 38 | Alnylam PharmaceuticalsALNY · Health Care | PLN 16.8B | PLN 84B | PLN 626.82 | 0.25% down | 66% down | ||
| 39 | Elanco Animal HealthELAN · Health Care | PLN 27.3B | PLN 52.7B | PLN 105.52 | 1.66% up | 20% up | ||
| 40 | Vertex PharmaceuticalsVRTX · Health Care | PLN 28B | PLN 546.2B | PLN 2,154.25 | 0.43% up | 27% up | ||
| 41 | GenmabGMAB · Health Care | PLN 28.2B | PLN 128.5B | PLN 208.47 | 0.08% down | 70% up | ||
| 42 | Jazz PharmaceuticalsJAZZ · Health Care | PLN 29.5B | PLN 62.3B | PLN 971.19 | 0.48% up | 37% up | ||
| 43 | Regeneron PharmaceuticalsREGN · Health Care | PLN 37.3B | PLN 401.4B | PLN 3,880.37 | 0.90% up | 36% up | ||
| 44 | Royalty PharmaRPRX · Health Care | PLN 39.8B | PLN 159.4B | PLN 277.23 | 0.53% up | 78% up | ||
| 45 | ZoetisZTS · Health Care | PLN 48.7B | PLN 137.1B | PLN 337.50 | 0.69% up | 29% down | ||
| 46 | GrifolsGRFS · Health Care | PLN 53.9B | PLN 23.6B | PLN 34.65 | 0.00% | 1% up | ||
| 47 | ViatrisVTRS · Health Care | PLN 90.3B | PLN 95B | PLN 82.87 | 0.93% up | 96% up | ||
| 48 | Teva Pharmaceutical IndustriesTEVA · Health Care | PLN 131.8B | PLN 201B | PLN 172.25 | 0.68% up | 74% up | ||
| 49 | Abbott LaboratoriesABT · Health Care | PLN 136.3B | PLN 733.7B | PLN 423.61 | 0.71% up | 17% down | ||
| 50 | Takeda PharmaceuticalTAK · Health Care | PLN 203.2B | PLN 277B | PLN 86.69 | 0.25% down | 54% up | ||
| 51 | Novo NordiskNVO · Health Care | PLN 207.9B | PLN 713.9B | PLN 161.98 | 0.90% down | 17% down | ||
| 52 | GSKGSK · Health Care | PLN 240.7B | PLN 397.4B | PLN 198.27 | 0.31% up | 6% up | ||
| 53 | SanofiSNY · Health Care | PLN 245.4B | PLN 459.4B | PLN 191.33 | 0.25% up | 4% down | ||
| 54 | NovartisNVS · Health Care | PLN 258.6B | PLN 1.2T | PLN 633.34 | 0.90% down | 25% up | ||
| 55 | AstraZenecaAZN · Health Care | PLN 262.4B | PLN 1.13T | PLN 727.12 | 0.62% down | 2% up | ||
| 56 | Bristol-Myers SquibbBMY · Health Care | PLN 287.2B | PLN 500.4B | PLN 244.81 | 0.67% down | 34% up | ||
| 57 | Merck & CoMRK · Health Care | PLN 338.1B | PLN 1.4T | PLN 566.41 | 1.63% down | 51% up | ||
| 58 | Eli LillyLLY · Health Care | PLN 345.1B | PLN 5.06T | PLN 5,685.97 | 0.05% up | 35% up | ||
| 59 | Johnson & JohnsonJNJ · Health Care | PLN 472.5B | PLN 2.69T | PLN 1,117.55 | 0.18% down | 38% up | ||
| 60 | PfizerPFE · Health Care | PLN 487.4B | PLN 651.7B | PLN 114.33 | 0.05% up | 14% up | ||
| 61 | AbbVieABBV · Health Care | PLN 550.8B | PLN 2.07T | PLN 1,171.27 | 0.39% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0153 PLN).
Questions and answers
Which pharmaceuticals have the lowest total liabilities?
Veradermics (PLN 36.8M), Belite Bio (PLN 40.4M) and Oruka Therapeutics (PLN 67M) have the lowest total liabilities of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 14:43 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total liabilities.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total liabilities have a combined market value of PLN 20.67T as of 18 Nov 2026, 14:43 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.